CureVac N.V. — key financial figures for fiscal year 2024 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2024)
- €535.2M
- Net Income/Loss (FY2024)
- €162.2M
- Total Assets (FY2024)
- €802.8M
- Total Equity (FY2024)
- €696.6M
- Cash Flows from Operating Activities (FY2024)
- €101.9M
Source: CureVac N.V. 20-F filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
